{
    "code": "02025782",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025782",
    "time": "2020-02-25 13:41:35",
    "許可證字號": "衛署藥輸字第025782號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/07\/31",
    "發證日期": "101\/07\/31",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202578208",
    "中文品名": "&quot;百博&quot;伏達諾平25毫克\/毫升靜脈凍晶注射劑",
    "英文品名": "Fludarabine BioPro 25mg\/ml, powder for solution for injection\/infusion",
    "適應症": "用於B細胞慢性淋巴性白血病(CLL)病患的起始治療及CLL與低惡性度非何杰金氏淋巴瘤(LG-NHL)病患，歷經至少一種標準內容的烷化基藥劑(ALKYLATING AGENT)的治療方法都無效，或治療後雖有效但隨後疾病又繼續惡化的病人。以本品作為第一線治療，只適用於重度病患即評估為RAI III\/IV階段(BINERT C級)或RAI I\/II(BINET A\/B級)但併有疾病相關症候或病情持續惡化的病人。",
    "劑型": "243凍晶注射劑",
    "包裝": "50公絲小瓶 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 24監視期滿學名藥",
        "申請商名稱": "620102Q259  百博生技有限公司",
        "申請商地址": "台北市大安區信義路4段6號15樓之4",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012001710",
            "成分名稱": "FLUDARABINE PHOSPHATE",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "伏達諾平_PI-105-06-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025782&Seq=002&Type=9"
        },
        {
            "title": "伏達諾平_Carton & Label-105-06-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025782&Seq=002&Type=8"
        }
    ]
}